iTeos Therapeutics's total assets for Q4 2024 were $686.98M, a decrease of -4.99% from the previous quarter. ITOS total liabilities were $96.68M for the fiscal quarter, a 5.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.